These changes were accompanied by lower expression of ADIPOQ in SAT, reduced plasma adiponectin and increased expression of genes involved in proteasomal degradation in skeletal muscle of patients with T2D compared with obese controls. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.